MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression

[1] Kubben FJ(2006)Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer Br J Cancer 94 1035-1040

[2] Sier CF(1996)Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas Int J Cancer 69 9-16

[3] van Duijn W(2010)Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma J Surg Oncol 103 243-247

[4] Griffioen G(2004)Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals J Biol Chem 279 19683-19690

[5] Hanemaaijer R(2009)Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin Carcinogenesis 30 1305-1313

[6] van de Velde CJ(2012)The mTOR Signalling Pathway in Human Cancer Int J Mol Sci 13 1886-1918

[7] Nomura H(2009)Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer Clin Cancer Res 15 1821-1829

[8] Fujimoto N(2009)Relation between outcomes and localisation of p-mTOR expression in gastric cancer Br J Cancer 100 782-788

[9] Seiki M(2010)Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer BMC Cancer 10 536-2566

[10] Mai M(2006)Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells Endocrinology 147 2557-4089

[1] Kubben FJ(2006)Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer Br J Cancer 94 1035-1040

[2] Sier CF(1996)Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas Int J Cancer 69 9-16

[3] van Duijn W(2010)Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma J Surg Oncol 103 243-247

[4] Griffioen G(2004)Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals J Biol Chem 279 19683-19690

[5] Hanemaaijer R(2009)Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin Carcinogenesis 30 1305-1313

[6] van de Velde CJ(2012)The mTOR Signalling Pathway in Human Cancer Int J Mol Sci 13 1886-1918

[7] Nomura H(2009)Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer Clin Cancer Res 15 1821-1829

[8] Fujimoto N(2009)Relation between outcomes and localisation of p-mTOR expression in gastric cancer Br J Cancer 100 782-788

[9] Seiki M(2010)Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer BMC Cancer 10 536-2566

[10] Mai M(2006)Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells Endocrinology 147 2557-4089